News Release

UMMS researchers identify new pathway to regenerate insulin-producing cells

Peer-Reviewed Publication

UMass Chan Medical School

Worcester, MA - Researchers at the University of Massachusetts Medical School have discovered a new pathway that triggers regeneration of beta cells in the pancreas, a key development that may aid in the development of diabetes treatments. The research was published online in The Journal of Clinical Investigation.

Insulin, a hormone that regulates blood sugar, is made in pancreatic beta cells. When insulin demand in the body exceeds beta cell insulin production capacity, prompted by events such as beta cell loss (type 1 diabetes) or weight gain (type 2 diabetes), beta cells proliferate to try to increase in number. Until now, it was unclear how beta cells sense the demand to more make insulin.

In an innovative study in mice, Laura Alonso, MD, associate professor of medicine and the George F. and Sybil H. Fuller Foundation Term Chair in Diabetes, and Rohit Sharma, PhD, a postdoctoral associate, discovered how the pancreas knows that more insulin-producing beta cells are needed. When there's an increase in insulin demand, there's a corresponding increase in insulin production in the endoplasmic reticulum (ER) of the beta cell, which causes some stress to the ER system. "Although it was previously known that too much ER stress is bad for beta cells, causing them to die, our study found that a modest amount of stress is actually good for them, because it provides pressure to increase beta cell number to produce more insulin and keep blood sugar regulated," Alonso said.

The research also uncovered a surprising twist. The study found ER stress pathways actually send a signal to the cell nucleus, via an ER protein called ATF6 that says "proliferate." Importantly, the study also found that the key elements of this pathway are active in human beta cells too. According to Alonso, these results explain why beta cells are so sensitive to stress, because they need to sense stress in order to determine how many beta cells are needed.

"This may also explain the conundrum of why there do not appear to be stem cells in the pancreas," Alonso added. "Only fully mature insulin-producing beta cells are able to use this stress mechanism to sense that the body needs more insulin than the current allotment of beta cells can provide."


The study will be published in the October issue of The Journal of Clinical Investigation.

About the University of Massachusetts Medical School

The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The Medical School attracts more than $240 million in research funding annually, 80 percent of which comes from federal funding sources. The mission of the Medical School is to advance the health and well-being of the people of the commonwealth and the world through pioneering education, research, public service and health care delivery with its clinical partner, UMass Memorial Health Care. For more information, visit

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.